AIF1 and Parkinson disease: Quantitative analysis revealed no significant difference between control subjects and PD patients in the percentage of microglial cell bodies positive for acetylated α-Tubulin (Supplementary Fig. 1g) and the co-localization between IBA1 and acetylated α-Tubulin (Mander’s coefficient; Supplementary Fig. 1h).